Vitamin C and α-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats

Carcinogenesis

Volumn 30, Issue 7, 2009, Pages 1202-1208

  Mense, Sarah M ^a   Singh, Bhupendra ^a   Remotti, Fabrizio ^b   Liu, Xinhua ^a   Bhat, Hari K ^a  

^a Columbia University ^*  (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYESTRADIOL; 4 HYDROXYESTRADIOL; ALPHA NAPHTHOFLAVONE; ASCORBIC ACID; ESTRADIOL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST TUMOR; CANCER INVASION; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ESTROGEN METABOLISM; EXPERIMENTAL NEOPLASM; FEMALE; HISTOPATHOLOGY; HORMONE ACTION; HORMONE INHIBITION; HYDROXYLATION; LIPID PEROXIDATION; MICROSOME; MULTIPLE CANCER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BENZOFLAVONES; CELL TRANSFORMATION, NEOPLASTIC; DINOPROST; ESTRADIOL; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; NEOPLASMS, HORMONE-DEPENDENT; OXIDATIVE STRESS; RATS; RATS, INBRED ACI;

EID: 67650159397     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp093     Document Type: Article

References (50)

1. Henderson,B.E. et al. (2000) Hormonal carcinogenesis. Carcinogenesis, 21, 427-433.
2. International Association for Research on Cancer. (1987) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC, Lyon.
3. International Association for Research on Cancer. (1999) Monographs on the Evaluation of Carcinogenic Risks to Humans: Hormonal Contraception and Postmenopausal Hormone Therapy. IARC, Lyon.
4. National Toxicology Program. (2002) Report on Carcinogens. National Toxicology Program, Research Triangle Park, NC.
5. Key,T. et al. (2002) Endogenous sex hormones and breast cancer in postmenopausal women: Reanalysis of nine prospective studies. J. Natl Cancer Inst., 94, 606-616.
6. Yager,J.D. et al. (2006) Estrogen carcinogenesis in breast cancer. N. Engl. J. Med., 354, 270-282.
7. Bhat,H.K. et al. (2003) Critical role of oxidative stress in estrogen-induced carcinogenesis. Proc. Natl Acad. Sci. USA, 100 3913-3918.
8. Cavalieri,E.L. et al. (2004) A unifying mechanism in the initiation of cancer and other diseases by catechol quinones. Ann. N. Y. Acad. Sci., 1028, 247-257.
9. Roy,D. et al. (1999) Estrogen, DNA damage and mutations. Mutat. Res., 424, 107-115.
10. Yager,J.D. (2000) Endogenous estrogens as carcinogens through metabolic activation. J. Natl Cancer Inst. Monogr., 27, 67-73.
11. Singh,K.P. et al. (2004) Somatic mutations in stilbene estrogen-induced Syrian hamster kidney tumors identified by DNA fingerprinting. J. Carcinog., 3, 4.
12. Cavalieri,E. et al. (2000) Estrogens as endogenous genotoxic agents - DNA adducts and mutations. J. Natl Cancer Inst. Monogr., 27, 75-93.
13. Harvell,D.M. et al. (2000) Rat strain-specific actions of 17beta-estradiol in the mammary gland: Correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers. Proc. Natl Acad. Sci. USA, 97 2779-2784.
14. Shull,J.D. et al. (1997) Ovary-intact, but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma. Carcinogenesis, 18, 1595-1601.
15. Arnerlov,C. et al. (2001) Intratumoral variations in DNA ploidy and s-phase fraction in human breast cancer. Anal. Cell. Pathol., 23, 21-28.
16. Li,J.J. et al. (2002) Ploidy differences between hormone- and chemical carcinogen-induced rat mammary neoplasms: Comparison to invasive human ductal breast cancer. Mol. Carcinog., 33, 56-65.
17. Li,J.J. et al. (2004) Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats. Proc. Natl Acad. Sci. USA, 101, 18123-18128.
18. Weroha,S.J. et al. (2006) Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats. Carcinogenesis, 27, 491-498.
19. Mense,S. et al. (2008) Estrogen-induced breast cancer: Alterations in breast morphology and oxidative stress as a function of estrogen exposure. Toxicol. Appl. Pharmacol., 232, 78-85.
20. Han,X. et al. (1994) DNA single-strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens: Hormone-induced free radical damage preceding renal malignancy. Carcinogenesis, 15, 997-1000.
21. Wang,M.Y. et al. (1995) Induction by estrogens of lipid peroxidation and lipid peroxide-derived malonaldehyde-DNA adducts in male Syrian hamsters: Role of lipid peroxidation in estrogen-induced kidney carcinogenesis. Carcinogenesis, 16, 1941-1945.
22. Roy,D. et al. (1989) Comparison of assays for catechol estrogen synthase activity: Product isolation vs radioenzymatic catechol-O-methyltransferase-coupled procedures. J. Steroid Biochem. 33, 243-249.
23. Zhu,B.T. et al. (1994) Conversion of estrone to 2- and 4-hydroxyestrone by hamster kidney and liver microsomes: Implications for the mechanism of estrogen-induced carcinogenesis. Endocrinology 135, 1772-1779.
24. Dignam,J.D. et al. (1977) NADPH-cytochrome P-450 reductase from rat liver: Purification by affinity chromatography and characterization. Biochemistry, 16, 1116-1123.
25. Shimada,T. et al. (1998) Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1. Chem. Res. Toxicol., 11, 1048-1056.
26. Guengerich,F.P. et al. (2003) Cytochrome P450 1B1: A target for inhibition in anticarcinogenesis strategies. Mutat. Res., 523-524, 173-182.
27. Liehr,J.G. et al. (1991) DNA adduct formation in liver and kidney of male Syrian hamsters treated with estrogen and/or alpha-naphthoflavone. Carcinogenesis, 12, 385-389.
28. Li,J.J. et al. (1984) High incidence of hepatocellular carcinomas after synthetic estrogen administration in Syrian golden hamsters fed alpha-naphthoflavone: A new tumor model. J. Natl Cancer Inst., 73, 543-547.
29. Milne,G.L. et al. (2007) Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat. Protoc., 2, 221-226.
30. Cavalieri,E. et al. (2006) Catechol estrogen quinones as initiators of breast and other human cancers: Implications for biomarkers of susceptibility and cancer prevention. Biochim. Biophys. Acta, 1766, 63-78.
31. Castagnetta,L.A. et al. (2002) Tissue content of hydroxyestrogens in relation to survival of breast cancer patients. Clin. Cancer Res. 8, 3146-3155.
32. Li,J.J. et al. (1987) Estrogen carcinogenesis in Syrian hamster tissues: Role of metabolism. Fed. Proc., 46, 1858-1863.
33. Newbold,R.R. et al. (2000) Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res., 60, 235-237.
34. Guengerich,F.P. (2003) Cytochromes P450, drugs, and diseases. Mol. Interv., 3, 194-204.
35. Li,S.A. et al. (1985) Estrogen 2- and 4-hydroxylase activity, catechol estrogen formation, and implications for estrogen carcinogenesis in the hamster kidney. Cancer Res., 45, 181-185.
36. Milne,G.L. et al. (2008) Human biochemistry of the isoprostane pathway. J. Biol. Chem., 283, 15533-15537.
37. Liehr,J.G. (1997) Dual role of oestrogens as hormones and pro-carcinogens: Tumour initiation by metabolic activation of oestrogens. Eur. J. Cancer Prev., 6, 3-10.
38. Liehr,J.G. (1999) 4-hydroxylation of oestrogens as a marker for mammary tumours. Biochem. Soc. Trans., 27, 318-323.
39. Li,S.A. et al. (1981) Changes in estrogen receptor levels during DES-induced hepatocarcinogenesis in the Syrian hamster fed alpha-naphthoflavone. J Steroid Biochem., 15, 387-392.
40. Liehr,J.G. et al. (1996) 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc. Natl Acad. Sci. USA, 93, 3294-3296.
41. Rogan,E.G. et al. (2003) Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer. Carcinogenesis, 24, 697-702.
42. Turan,V.K. et al. (2004) The effects of steroidal estrogens in ACI rat mammary carcinogenesis: 17beta-estradiol, 2-hydroxyestradiol, 4-hydroxyestradiol, 16alpha-hydroxyestradiol, and 4-hydroxyestrone. J. Endocrinol., 183, 91-99.
43. Howe,G.R. et al. (1990) Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J. Natl Cancer Inst. 82, 561-569.
44. Garland,M. et al. (1993) Antioxidant micronutrients and breast cancer. J. Am. Coll. Nutr., 12, 400-411.
45. Hunter,D.J. et al. (1993) A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer. N. Engl. J. Med. 329, 234-240.
46. Kushi,L.H. et al. (1996) Intake of vitamins A, C, and E and postmenopausal breast cancer. The Iowa Women's Health Study. Am. J. Epidemiol., 144, 165-174.
47. Rohan,T.E. et al. (1993) Dietary fiber, vitamins A, C, and E, and risk of breast cancer: A cohort study. Cancer Causes Control, 4 29-37.
48. Verhoeven,D.T. et al. (1997) Vitamins C and E, retinol, beta-carotene and dietary fibre in relation to breast cancer risk: A prospective cohort study. Br. J. Cancer, 75, 149-155.
49. Zhang,S. et al. (1999) Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. J. Natl Cancer Inst., 91, 547-556.
50. Michels,K.B. et al. (2001) Dietary antioxidant vitamins, retinol, and breast cancer incidence in a cohort of Swedish women. Int. J. Cancer, 91, 563-567.